Abstract:172 Background: Lemur tail kinase 3 (LMTK3) plays a critical role in multiple cellular pathways such as Wnt signaling, KIT modulation, and the estrogen receptor pathway. We previously reported that LMTK3 gene polymorphisms are associated with clinical outcome in patients with CRC, and that LMTK3 and estrogen-mediated signaling play a crucial role in CRC tumorigenesis in vitro. Here, we aimed to characterize the molecular features associated with LMTK3 gene expression in CRC. Methods: 20,219 CRC were tested at Caris Life Sciences (Phoenix, AZ) with NextGen Sequencing on DNA (592 genes or WES) and RNA (WTS). Top quartile transcripts per million (TPM) for LMTK3 expression (Q4) were considered high while bottom quartile (Q1) low. Consensus molecular subtypes (CMS) were assessed using RNAseq. Cell infiltration (CI) in the tumor microenvironment (TME) was estimated by QuantiSEQ. X 2 and Fisher-Exact tests were used, and significance was determined as p-value adjusted for multiple comparisons ( q < 0.05). Gene expression profiles were analyzed for transcriptional signatures predictive of response to immunotherapy (interferon gamma [IFNγ] score; T-cell inflamed signature [TIS] score). Results: LMTK3 expression was highest in left-sided (0.98 median TPM) followed by right-sided (0.96) and lowest in rectal tumors (0.92). No difference in patient sex distribution was observed between Q1 and Q4 cohorts. Overall, LMTK3 Q1 was associated with TMB-high (≥ 10 Mut/Mb, 11.4 vs 8.7%) and dMMR/MSI-H (8.1 vs 4.6%) ( q < 0.0001); however, these associations were no longer significant in pMMR/MSS tumors. In the pMMR/MSS cohort, LMTK3 expression was highest in CMS4 (1.09 median TPM) followed by CMS2 (0.98), CMS1 (0.88), and lowest in CMS3 (0.70, all intergroup q < 0.05). LMTK3 high showed differential rates of mutations and copy number alterations (CNA) in several genes, including higher mutation rates of APC, TP53, and CDX2 CNA, while lower mutation rates of KMT2A/D, ASXL1, ATM, SMAD4, RNF43 and AMER1 in the overall cohort ( q < 0.05). In the pMMR/MSS cohort, the associations with APC, TP53, SMAD4 and ATM mutations and CDX2 CNA still held true ( q < 0.05). High LMTK3 was associated with higher immune CI in the TME, including B cells, neutrophils, NK cells, CD4+ T cells, monocytes and dendritic cells, while macrophages and Tregs were lower regardless of tumor MSI status (fold change: 0.83-2.4, all q < 0.0001). The IFNγ score was significantly lower in LMTK3 Q4 while the TIS score was significantly higher in LMTK3 Q4 ( q < 0.0001). Conclusions: Our data show a strong association between LMTK3 gene expression and distinct molecular features and TME immune cell infiltration in CRC. These findings suggest that LMTK3 may be an important molecular factor that plays a role in determining the composition of the TME, thus targeting LMTK3 could represent a novel strategy in selected CRC subgroups.

Upregulation of the Transmembrane Protease Serine 3 (TMPRSS3) Mrna Level in Radioresistant Colorectal Cancer Tissues

Upregulation of the Transmembrane Protease Serine 3 Mrna Level in Radioresistant Colorectal Cancer Tissues.

High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients

Tmprss4 Correlates With Colorectal Cancer Pathological Stage And Regulates Cell Proliferation And Self-Renewal Ability

PIM3 Functions As Oncogenic Factor and Promotes the Tumor Growth and Metastasis in Colorectal Cancer

Expression of TMED3 is Independently Associated with Colorectal Cancer Prognosis

PRL-3 and MMP9 Expression and Epithelial-Mesenchymal Transition Markers in Circulating Tumor Cells from Patients with Colorectal Cancer: Potential Value in Clinical Practice.

Multidrug Resistance-Associated Protein 3 Confers Resistance to Chemoradiotherapy for Rectal Cancer by Regulating Reactive Oxygen Species and Caspase-3-dependent Apoptotic Pathway.

A comprehensive analysis of TRP-related gene signature, and immune infiltration in patients with colorectal cancer

CPT1A Mediates Radiation Sensitivity in Colorectal Cancer

Exploiting tertiary lymphoid structures gene signature to evaluate tumor microenvironment infiltration and immunotherapy response in colorectal cancer

TMPRSS2 Serves As a Prognostic Biomarker and Correlated with Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma

Overexpression of Tbx3 is Correlated with Epithelial-Mesenchymal Transition Phenotype and Predicts Poor Prognosis of Colorectal Cancer.

Overexpression of the Transcription Factor ATF3 with a Regulatory Molecular Signature Associates with the Pathogenic Development of Colorectal Cancer

TMUB1 as a diagnostic and prognostic marker for colorectal cancer

Integrated Transcriptional Profiling and Genomic Analyses Reveal RPN2 and HMGB1 As Promising Biomarkers in Colorectal Cancer

TPM3: a novel prognostic biomarker of cervical cancer that correlates with immune infiltration and promotes malignant behavior in vivo and in vitro

Pregnane X Receptor is Associated with Unfavorable Survival and Induces Chemotherapeutic Resistance by Transcriptional Activating Multidrug Resistance-Related Protein 3 in Colorectal Cancer.

TGM3 functions as a tumor suppressor by repressing epithelial‑to‑mesenchymal transition and the PI3K/AKT signaling pathway in colorectal cancer.

LMTK3 gene expression and the molecular landscape of colorectal cancer (CRC).

IDDF2018-ABS-0233 N6-adenosine Methyltransferase METTL3 Promotes Tumour Metastasis Via SOX2 MRNA M6A Modification in Colorectal Carcinoma